Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
7250
Trial Sponsor
Clinical Trial Start Date
November 16, 2018
0Primary Completion Date
April 8, 2020
0Study Completion Date
April 8, 2020
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Behavioral0
Intervention Name
Thrive0
Interventional Trial Phase
Not Applicable0
Participating Facility
Official Name
Thrive-Montana: A Computerized Cognitive Behavior Therapy (cCBT) Program to Reduce Depression, Anxiety, Suicidal Ideation and Behaviors for Rural Montanans0
Last Updated
September 2, 2020
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Study summary
This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among adults. The first 450 participants will participate in a randomized waitlist controlled trial. The remaining 550 participants will be provided the program immediately upon enrolling
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.

